Multicentre Retrospective Cohort Study of Palliative Care Pathways in Patients Who Died From Sarcoma
NCT07532668 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 207
Last updated 2026-04-16
Summary
The goal of this observational study is to describe palliative pathways in adult patients who died from their sarcoma.
The main question it aims to answer is:
How patients who died from sarcoma are followed by palliative team.
Conditions
- Sarcoma
Sponsors & Collaborators
-
Institut Curie
collaborator OTHER -
Gustave Roussy, Cancer Campus, Grand Paris
collaborator OTHER -
Centre Leon Berard
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-01
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- France
Study Locations
More Related Trials
-
Observational Study in Localized Osteosarcoma
NCT04890067 ·Status: RECRUITING
-
Pain Prevalence and Risk Factors Among Sarcoma/Melanoma Oncology Patients in an Outpatients Setting
NCT01034696 ·Status: COMPLETED
-
Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma
NCT01455363 ·Status: COMPLETED ·Phase: NA
-
Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma
NCT06309836 ·Status: RECRUITING
-
Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face
NCT04485442 ·Status: ACTIVE_NOT_RECRUITING
-
Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies
NCT03673332 ·Status: TERMINATED ·Phase: PHASE4
-
Burden and Medical Care of Sarcoma in Germany
NCT03521531 ·Status: COMPLETED
-
Biomarker-driven Therapy for Melanoma
NCT05063058 ·Status: COMPLETED ·Phase: NA
-
MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma
NCT04216953 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tracing Dissemination of Melanoma Cells in Healthy Tissues
NCT02854124 ·Status: COMPLETED
-
Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients
NCT06039046 ·Status: NOT_YET_RECRUITING
-
Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis
NCT02537600 ·Status: COMPLETED ·Phase: PHASE2
-
Recurrence Rate and Esthetic Outcome After Excision of Basal Cell Carcinomas Excluded From Trial NCT00515970
NCT00639652 ·Status: UNKNOWN
-
Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle
NCT00181025 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of RO5185426 in Previously Treated Melanoma Patients With Brain Metastases
NCT01253564 ·Status: COMPLETED ·Phase: PHASE2
-
Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Predictive Factor of Response to Anti-PD-1
NCT05856565 ·Status: RECRUITING
-
Variations of Immune Infiltrate and Cell Plasticity Markers in Treated Metastatic Melanoma Patients
NCT05029791 ·Status: RECRUITING ·Phase: NA
-
QUEST: QUality of Life and Experiences of Sarcoma Trajectories
NCT03441906 ·Status: UNKNOWN
-
Cutaneous Squamous Cell Carcinoma Staging Study
NCT05695222 ·Status: RECRUITING
-
Stage IV Surgery Versus Best Medical Therapy
NCT01013623 ·Status: TERMINATED ·Phase: PHASE3
-
Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma
NCT04472806 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of a Range of Dermo-cosmetic Products to Treat Skin and Nail Toxicity Linked to Bispecific Anti-GPRC5D Bispecific Antibodies in Multiple Myeloma Patients". Myeloma". Descriptive Pilot Study
NCT06418750 ·Status: COMPLETED ·Phase: NA
-
Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples
NCT01744860 ·Status: COMPLETED
-
A Study of RO5185426 in Patients With Metastatic Melanoma
NCT01248936 ·Status: COMPLETED ·Phase: PHASE2
-
COmparison of the Use of a PERforator Flap Versus Total Skin GRAft in the Management of Loss of Substance After Resection of Cutaneous Melanoma - Pilot Study
NCT07354152 ·Status: RECRUITING